RxDoctor Payments Data

Tricia Vorderstrasse, MD

Family Medicine · Gardner, MANPI 1619953247

Payments from drug & device makers

$533in general payments, 2019–2025

Across 29 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$98
  • Medtronic$73
  • Mylan Specialty L.p.$71
  • AbbVie$48
  • Sanofi Pasteur Inc.$37
  • Lilly USA, LLC$35
  • plus $171 from 8 others

What the payments were for

  • Food & beverage$533100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$533 in reported general payments places this provider in the 75th percentile of 1,049 family medicine providers in Massachusetts.

See all family medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$369,357
Medicare patients
504
Services billed
4,909

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban533$190,784
Trelegy ElliptaFluticasone/Umeclidin/Vilanter156$150,450
Breztri AerosphereBudesonide/Glycopyr/Formoterol46$50,937
TrulicityDulaglutide55$39,789
XareltoRivaroxaban23$31,966
OzempicSemaglutide21$24,562
Breo ElliptaFluticasone/Vilanterol41$23,068
ArexvyRsvpref3 Antigen/As01e/Pf47$14,844
TrintellixVortioxetine Hydrobromide69$12,933
EntrestoSacubitril/Valsartan13$12,743
JanuviaSitagliptin Phosphate43$12,387
TradjentaLinagliptin14$12,291
CreonLipase/Protease/Amylase15$9,471
Combivent RespimatIpratropium/Albuterol Sulfate16$9,441
PentasaMesalamine48$9,386

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Arexvy, Incruse Ellipta$98$196,638264 claims
AstraZenecaBreztri Aerosphere, Symbicort, Farxiga$24$66,78479 claims
Lilly USA, LLCTrulicity, Olanzapine$35$44,159347 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$11$12,93369 claims
MerckJanuvia$14$12,38743 claims
AbbVieCreon$48$9,47115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,049 family medicine providers in Massachusetts.

Other family medicine in Gardner

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →